Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CNS Pharmaceuticals, Inc. (CNSP) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 8-K Quarterly results
08/15/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "AMENDED AND RESTATED BYLAWS OF CNS PHARMACEUTICALS, INC."
08/14/2023 8-K Quarterly results
Docs: "CNS Pharmaceuticals Reports Second Quarter 2023 Financial Results and"
05/15/2023 8-K Quarterly results
Docs: "CNS Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides"
05/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Bettina M. Cockroft, M.D., M.B.A., Pharmaceutical and Biotech Industry Veteran, Joins CNS Pharmaceuticals Board of Directors"
01/03/2023 8-K Appointed a new director
Docs: "CNS Pharmaceuticals Appoints Faith L. Charles, JD as Chair of the Board of Directors"
12/14/2022 8-K Quarterly results
12/01/2022 8-K Quarterly results
11/28/2022 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Amendment to the Amended and Restated Articles of Incorporation of CNS Pharmaceuticals, Inc., filed with the Secretary of State of the State of Nevada",
"CNS Pharmaceuticals Announces Reverse Stock Split"
10/24/2022 8-K Quarterly results
08/26/2022 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
08/19/2022 8-K Quarterly results
08/16/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
07/28/2022 8-K Quarterly results
05/16/2022 8-K Quarterly results
03/03/2022 8-K Quarterly results
02/18/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
01/10/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "INVESTOR PRESENTATION"
01/06/2022 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "FORM OF WARRANT",
"FORM OF PRE-FUNDED WARRANT",
"FORM OF SECURITIES PURCHASE AGREEMENT",
"FORM OF REGISTRATION RIGHTS AGREEMENT",
"2100 West Loop South, Suite 900"
12/03/2021 8-K Quarterly results
08/13/2021 8-K Quarterly results
Docs: "CNS Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Outlook"
07/19/2021 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "CNS Pharmaceuticals, Inc. Investor Presentation – July 2021"
07/01/2021 8-K Submission of Matters to a Vote of Security Holders, Other Events
05/18/2021 8-K Quarterly results
03/17/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
02/12/2021 8-K Quarterly results
01/07/2021 8-K Quarterly results
12/28/2020 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Underwriting Agreement, with A.G.P./Alliance Global Partners, as representative of the several underwriters",
"Form of Warrant",
"Press release"
12/21/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Portions of “Prospectus Summary” and “Risk Factors” section of CNS Pharmaceuticals, Inc.’ s Registration Statement on Form S-1 filed December 21, 2020"
12/11/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "CNS Pharmaceuticals, Inc. Investor Presentation – December 2020"
11/12/2020 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "CNS Pharmaceuticals, Inc. Investor Presentation – November 2020"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy